Cargando…

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

INTRODUCTION: Kawasaki disease (KD), an acute febrile disease, characterized by systemic vasculitis, predominantly affects infants and children under 5 years of age. Coronary artery lesions (CALs) are its most critical complication, and the etiology remains unknown yet. In order to explore the value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yanqi, Gong, Fangqi, Zhang, Qing, Xie, Chunhong, Wang, Wei, Fu, Songling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674612/ https://www.ncbi.nlm.nih.gov/pubmed/23171632 http://dx.doi.org/10.1186/ar4094

Ejemplares similares

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Notch4 signaling pathway in a Kawasaki disease mouse model induced by Lactobacillus casei cell wall extract
por: Gao, Lichao, et al.
Publicado: (2017)

A new model to predict intravenous immunoglobin-resistant Kawasaki disease
por: Hua, Wang, et al.
Publicado: (2017)

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease
por: Qi, Yanqi, et al.
Publicado: (2021)

The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury
por: Gao, Lichao, et al.
Publicado: (2023)

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease
por: Sun, Yameng, et al.
Publicado: (2020)

Crucial transcripts predict response to initial immunoglobulin treatment in acute Kawasaki disease
por: Geng, Zhimin, et al.
Publicado: (2020)

Altered Monocyte Subsets in Kawasaki Disease Revealed by Single-cell RNA-Sequencing
por: Geng, Zhimin, et al.
Publicado: (2021)

KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
por: Zheng, Fenglei, et al.
Publicado: (2021)

The role of Ca(2+)/NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease
por: Wang, Ying, et al.
Publicado: (2020)

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
por: Ehlermann, Philipp, et al.
Publicado: (2006)

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
por: Sanguineti, Roberta, et al.
Publicado: (2014)

Association of circulating resistin and adiponectin levels with Kawasaki disease: A meta-analysis
por: Cai, Xintian, et al.
Publicado: (2020)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

Association of the Resistin Gene Promoter Region Polymorphism with Kawasaki Disease in Chinese Children
por: Liu, Ruixi, et al.
Publicado: (2012)

SAT-334 Proinflammatory Cytokines Modulate Resistin Expression in Breast Cancer Cells
por: Avtanski, Dimiter, et al.
Publicado: (2019)

Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes
por: Fu, Yuchang, et al.
Publicado: (2006)

The Serum Levels of Resistin and Its Relationship with Other Proinflammatory Cytokines in Patients with Alzheimer’s Disease
por: Demirci, Seden, et al.
Publicado: (2017)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
por: Aggarwal, Amita, et al.
Publicado: (2011)

Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein
por: Zhou, Shulai, et al.
Publicado: (2015)

Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes
por: Nagaev, Ivan, et al.
Publicado: (2006)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells
por: Franke, Sybille, et al.
Publicado: (2009)

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
por: Chen, Yueh-Sheng, et al.
Publicado: (2009)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
por: Hoffman, William H., et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

MTHFR C677T Polymorphism and Risk of Congenital Heart Defects: Evidence from 29 Case-Control and TDT Studies
por: Wang, Wei, et al.
Publicado: (2013)

A Genetic Variant rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis
por: Duan, Jiayu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ti7p5me43ep8e02ut8o9ltbhvp